The JDP2 gene is located on human chromosome 14q24.3. The gene spans approximately 46.4 kilobases, from base pair 75,427,715 to 75,474,111 . The protein itself consists of 163 amino acids and belongs to the basic leucine zipper (bZIP) family of transcription factors. The bZIP domain, which is essential for DNA binding and dimerization, includes amino acids from position 72 to 135 .
JDP2 functions primarily as a transcriptional repressor. It dimerizes with c-Jun, another member of the AP-1 family, to repress AP-1-mediated transcriptional activation . This repression is crucial for regulating various cellular processes, including cell proliferation, differentiation, and apoptosis.
JDP2 also interacts with other transcription factors, such as Activating Transcription Factor 2 (ATF2), to modulate gene expression. It regulates the 12-O-tetradecanoylphorbol-13-acetate (TPA) response element (TRE) and cAMP-responsive element (CRE)-dependent transcription .
JDP2 is involved in several biological processes, including:
JDP2 has been implicated in various diseases and conditions. For instance, it is associated with granulomatous amebic encephalitis and primary amebic meningoencephalitis . Additionally, JDP2’s role in regulating oxidative stress and inflammation makes it a potential target for therapeutic interventions in cancer and other inflammatory diseases .
Recombinant JDP2 is produced using recombinant DNA technology, which involves inserting the JDP2 gene into a suitable expression system, such as bacteria or yeast, to produce the protein in large quantities. This recombinant protein is used in various research applications to study its function, interactions, and potential therapeutic uses.